This app isn't in any of our charts yet.
Initial release
This app is for registered study participants of GSK SYLVER 221971 only
This app has been created exclusively for participants in the medical study for GSK SYLVER 221971. It contains Televisit functionality and allows participants to complete questionnaires. A Phase 1/2 Master Protocol to Assess the Safety and Efficacy of DNA-Damage Repair Inhibitors, as Monotherapies or in Combination with Other Anti-Cancer Agents in Adult Participants with Solid Tumors (SYLVER).
Not enough data yet.
Google Play only. Downloads from daily Top free ranks (or the store's install count); in-app revenue from Top grossing ranks, calibrated on AppTweak's US estimates, or else from downloads; ads from public ad benchmarks. Not reported figures.